Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs79718798 | chr2:121545716 | A/G | 0.000238 | 175 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs79722094 | chr11:18149564 | G/A | 4.13E-6 | 176 | 27.2 | 23.48 | 10.3 | KM Plot |
PCPG | rs79739807 | chr2:118718789 | A/G | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs79750959 | chr12:56702012 | C/A | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs7976187 | chr12:53504373 | T/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs79763140 | chr7:158864131 | C/A | 0 | 175 | 25.4 | 41.8 | 3.17 | KM Plot |
PCPG | rs7976409 | chr12:21635605 | G/A | 2.47E-8 | 175 | 25.28 | 25.67 | 2.28 | KM Plot |
PCPG | rs7976415 | chr12:21635625 | G/A | 2.45E-8 | 175 | 25.17 | 26.47 | 2.28 | KM Plot |
PCPG | rs79767670 | chr2:118581115 | C/T | 1.95E-5 | 176 | 25.28 | 28.45 | 11.65 | KM Plot |
PCPG | rs79786652 | chr7:36171054 | G/A | 0.000426 | 177 | 25.67 | 24.7 | 14.37 | KM Plot |
PCPG | rs79820208 | chr7:36174873 | T/C | 0.000433 | 177 | 25.6 | 24.6 | 14.37 | KM Plot |
PCPG | rs79820245 | chr7:36184505 | C/A | 0.000423 | 178 | 25.67 | 24.6 | 14.37 | KM Plot |
PCPG | rs79820374 | chr1:150924167 | G/A | 6.28E-5 | 171 | 24.23 | 41.27 | 15 | KM Plot |
PCPG | rs79824801 | chr12:56728137 | T/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs7982674 | chr13:37578090 | G/C | 0.000272 | 178 | 4.17 | 25 | 25.47 | KM Plot |